The Elekta Unity high-field MR-linac is now CE marked. (Courtesy: Elekta) Elekta has announced that its Unity MRI-guided radiotherapy system (MR/RT) system has received the CE mark, clearing the ...

Through intelligent and pioneering design, ElektaUnity(MR-linac)combines the best of both worlds to create a new paradigm for cancer careand provide extraordinary potential for'hard to treat' cancers ...

Stockholm-based Elekta has begun clinical trials on its Unity machine, which combines a linear accelerator and high-field magnetic resonance imaging (MRI) to better define and track tumors during ...

UPPSALA, Sweden, Nov. 14, 2019 /PRNewswire/ -- Sweden's first-ever patient to be treated on the groundbreaking Elekta Unity MR-Linac radiation therapy system took place at Uppsala University Hospital ...

Advances in magnetic resonance radiation therapy (MR/RT) has the potential to transform accuracy, efficiency and clinical outcomes in radiation therapy. Elekta (EKTA-B.ST) announced that Elekta Unity, ...

In the field of cancer treatment, radiation therapy (RT) plays a crucial role in combating this formidable disease. Technological advancements, particularly in advanced linear accelerators (linacs), ...

TOWNSVILLE, Australia, Dec. 10, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that Townsville Hospital in Queensland has treated the first patient in Australia using Elekta Unity MR-Linac, a ...

The Elekta Unity MRI-guided radiotherapy system can now be implemented clinically in the US. (Courtesy: Elekta) The Elekta Unity MRI-guided radiotherapy system has received 510(k) premarket ...

Elekta (EKTA-B.ST) earlier today announced (14:15 CET) that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark, clearing the technology for commercial sales and ...

Elekta Unity combines advanced diagnostic standard MR imaging and precision radiotherapy technologies, giving doctors the “vision” to zero in on tumors and avoid healthy tissues On July 25, the ...

New radiation therapy system will now be implemented clinically in Europe, ushering in a transformation in precision andpersonalized cancer treatment Elekta (EKTA-B.ST) earlier today announced (14:15 ...